The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Ascitic fluid analysis in malignancy-related ascites
Abstract
A prospective study identified 45 patients with malignancy-related ascites among 448 ascites patients (10% of the total). Patients were categorized into five subgroups based on the pathophysiology of ascites formation. Each subgroup had a distinctive ascitic fluid analysis. Patients with peritoneal carcinomatosis but without massive liver metastases (53.3% of the patients with malignancy-related ascites) had a uniformly positive ascitic fluid cytology, high ascitic fluid protein concentration and low serum-ascites albumin gradient. Patients with massive liver metastases and no other cause for ascites formation (13.3% of the series) had a negative cytology, low ascitic fluid protein concentration, high serum-ascites albumin gradient and markedly elevated serum alkaline phosphatase. Those with peritoneal carcinomatosis and massive liver metastases (13.3% of the series) had a nearly uniformly positive ascitic fluid cytology, variable protein concentration, high serum-ascites albumin gradient and markedly elevated serum alkaline phosphatase. Chylous ascites (6.7%) was characterized by a milky appearance, negative cytology and an elevated ascitic fluid triglyceride concentration. Patients with hepatocellular carcinoma superimposed on cirrhosis (13.3%) had negative ascitic fluid cytology, low ascitic fluid protein concentration, high serum-ascites albumin gradient and elevated serum and ascitic fluid α-fetoprotein concentration. Two-thirds of patients with malignancy-related ascites had peritoneal carcinomatosis; 96.7% of patients with peritoneal carcinomatosis had positive ascitic fluid cytology. Ascitic fluid analysis is helpful in identifying and distinguishing the subgroups of malignancy-related ascites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation and Management of Chylous Ascites
PRESS, O. W., PRESS, N. O., & KAUFMAN, S. D. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-3-358 · Cited by 326
Malignant Ascites: Clinical and Experimental Observations
GARRISON, R. N., KAELIN, L. D., HEUSER, L. S., & GALLOWAY, R. H. (1986) · Annals of Surgery · doi:10.1097/00000658-198606000-00009 · Cited by 208
Paré, P., Talbot, J., & Hoefs, J. C. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90306-2 · Cited by 175
Self-citationJc, H. (1983) · PubMed · Cited by 165
Runyon, B. A., Umland, E. T., & Merlin, T. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.1.73 · Cited by 130
Self-citationRector, W. G., & Reynolds, T. B. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90440-6 · Cited by 113
Cited by
Management of adult patients with ascites due to cirrhosis: An update†‡§
Runyon, B. A. (2009) · Hepatology · doi:10.1002/hep.22853 · Cited by 975
Self-citationGuidelines on the management of ascites in cirrhosis
Aithal, G. P., Palaniyappan, N., China, L., Härmälä, S., Macken, L., Ryan, J. M., Wilkes, E. A., Moore, K., Leithead, J. A., Hayes, P. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321790 · Cited by 680
Runyon, B. A., Montano, A. A., Akriviadis, E. A., Antillon, M. R., Irving, M. A., & McHutchison, J. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-215 · Cited by 651
Self-citationManagement of adult patients with ascites caused by cirrhosis†
Runyon, B. A. (1998) · Hepatology · doi:10.1002/hep.510270139 · Cited by 498
Self-citationAhmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Metadata
- Authors
- Runyon, B. A., Hoefs, J. C., & Morgan, T. R.
- Venue
- Hepatology
- Published
- 1988-09
- Volume
- 8
- Issue
- 5
- Pages
- 1104-1109
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2113746674
- Cited by
- 361
- References
- 6
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ascitic fluid analysis in malignancy-related ascites. https://app.cochat.ai/papers/10.1002/hep.1840080521
- The paper
- Runyon, B. A., Hoefs, J. C., & Morgan, T. R. (1988). Ascitic fluid analysis in malignancy-related ascites. Hepatology. https://doi.org/10.1002/hep.1840080521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.